Ibu and Haematocrit abnormal - a phase IV clinical study of FDA data

Summary:

Haematocrit abnormal is reported as a side effect among people who take Ibu (ibuprofen), especially for people who are female, 50-59 old, have been taking the drug for 2 - 5 years also take Tylenol, and have Back disorder.

The phase IV clinical study analyzes which people have Haematocrit abnormal when taking Ibu. It is created by eHealthMe based on reports of 240,078 people who have side effects when taking Ibu from the FDA, and is updated regularly.

What is Ibu?

Ibu has active ingredients of ibuprofen. It is often used in pain. eHealthMe is studying from 246,531 Ibu users. Check the latest studies of Ibu.

What is Haematocrit abnormal?

Haematocrit abnormal is found to be associated with 280 drugs and 595 conditions by eHealthMe. Check the latest studies of Haematocrit abnormal.

On Jul, 18, 2026

240,078 people reported to have side effects when taking Ibu.
Among them, 18 people (0.01%) have Haematocrit abnormal.

Among these 18 people:

How long have people been on Ibu when they have Haematocrit abnormal? *

What is the gender of people who have Haematocrit abnormal when taking Ibu? *

female: 60 %
male: 40 %

What is the age of people who have Haematocrit abnormal when taking Ibu? *

What are other drugs people take besides Ibu? *

What are other side effects people have besides Haematocrit abnormal? *

Dizziness: 6 people, 33.33%
Platelet Count Abnormal: 5 people, 27.78%
Abdominal Pain: 4 people, 22.22%
Nausea (feeling of having an urge to vomit): 4 people, 22.22%
Haemoglobin Abnormal: 4 people, 22.22%
Weakness: 3 people, 16.67%
Fatigue (feeling of tiredness): 3 people, 16.67%
Fall: 3 people, 16.67%
Nausea And Vomiting: 3 people, 16.67%
Diarrhea: 2 people, 11.11%

What are the existing conditions these people have? *

Intervertebral Disc Protrusion (spinal disc protrusion): 2 people, 11.11%
Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 2 people, 11.11%
Back Disorder: 2 people, 11.11%
Insomnia (sleeplessness): 1 person, 5.56%
Adenocarcinoma (malignant tumour formed from glandular structures in epithelial tissue): 1 person, 5.56%
Anaemia (lack of blood): 1 person, 5.56%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 5.56%
Cellulitis (infection under the skin): 1 person, 5.56%
Gastric Ulcer Haemorrhage (bleeding ulcer of stomach): 1 person, 5.56%
High Blood Cholesterol: 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Ibu and have Haematocrit abnormal?

- Check whether Haematocrit abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ibu:

Ibu (246,531 reports)

Browse all side effects of Ibu:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Haematocrit abnormal:

Haematocrit abnormal (280 drugs)

Browse all the conditions that are associated with Haematocrit abnormal:

Haematocrit abnormal (595 conditions)

Related publications that referenced our studies

Moslim MA, Sodeman TC, Nawras AT, "A Case of Suggested Ibuprofen-Induced Acute Pancreatitis", American journal of therapeutics, 2016 Nov .
Moslim MA, Sodeman TC, Nawras AT, "A Case of Suggested Ibuprofen-Induced Acute Pancreatitis", American journal of therapeutics, 2016 Nov .

How the study uses the data?

The study uses data from the FDA. It is based on ibuprofen (the active ingredients of Ibu) and Ibu (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.